Author:
Wittayanukorn Saranrat,Rosenberg Matthew,Schick Andreas,Hu Meng,Wang Zhong,Babiskin Andrew,Lionberger Robert,Zhao Liang
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference35 articles.
1. Office of the Assistant Secretary for Planning and Evaluation. U.S. Department of Health & Human Services. Observations on trends in prescription drug spending. 2016. https://aspe.hhs.gov/pdf-report/observations-trends-prescription-drug-spending. Accessed 18 Sept 2018.
2. IQVIA Institute for Human Data Science. Medicine Use and Spending in the U.S. A Review of 2017 and Outlook to 2022. https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022. Updated April 2018.
3. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858–71.
4. Reiffen D, Ward MR. Generic drug industry dynamics. Rev Econ Stat. 2005;87(1):37–49.
5. Association for Accessible Medicines. 2017 Generic drug access and savings in the U.S. Report. 2017. https://accessiblemeds.org/sites/default/files/2017-07/2017-AAM-Access-Savings-Report-2017-web2.pdf. Accessed 02 Feb 2018.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献